microrna microarray analyses (Toray Industries)
Structured Review
Microrna Microarray Analyses, supplied by Toray Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirna+microarray+data+analysis/mirna+microarray+analysis/pmc03590667-18-0-11
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Article Snippet: Background.. Whether radiation should be added to neoadjuvant treatment remains controversial, and liquid biopsy has not been reported to predict radioresistance in pancreatic cancer (PC).. We aimed to identify microRNAs (miRNAs) governing radioresistance in PC by utilizing peripheral plasma exosome samples and to verify their usefulness as biomarkers. Article Title: MicroRNA‐181b‐5p, ETS1, and the c‐Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy Article Snippet: .. Article Title: Integrated extracellular microRNA profiling for ovarian cancer screening Article Snippet: .. From all samples, we obtained comprehensive profiles of 2588 miRNAs using highly Article Title: miRNA-93 in Serum Extracellular Vesicles Before and After Low Dose Rate Prostate Brachytherapy. Article Snippet: Background/Aim: To identify novel biomarkers for prostate cancer (PC), we evaluated changes of miRNAs contained in serum small extracellular vesicles (EVs) in patients who received low dose rate prostate brachytherapy (BT).. Materials and Methods: EVs were isolated from the pooled serum of 10 PC patients prior to and 1 month after BT. miRNA profiling and quantitation in EVs was performed by microarray analysis and RT-digital PCR, respectively.. Expression of miRNA-93 in prostate tissue was evaluated using the TCGA database and its level in EVs was determined in 25 patients before and 1, 3, 6 and 12 months after BT. Article Title: Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer Article Snippet: .. From all samples, comprehensive profiles of 2565 miRNAs were obtained using a highly Article Title: MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma Article Snippet: .. Labeling:Article Title: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Article Snippet: Background.. Whether radiation should be added to neoadjuvant treatment remains controversial, and liquid biopsy has not been reported to predict radioresistance in pancreatic cancer (PC).. We aimed to identify microRNAs (miRNAs) governing radioresistance in PC by utilizing peripheral plasma exosome samples and to verify their usefulness as biomarkers. Extraction:Article Title: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Article Snippet: Background.. Whether radiation should be added to neoadjuvant treatment remains controversial, and liquid biopsy has not been reported to predict radioresistance in pancreatic cancer (PC).. We aimed to identify microRNAs (miRNAs) governing radioresistance in PC by utilizing peripheral plasma exosome samples and to verify their usefulness as biomarkers. Software:Article Title: miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Article Snippet: Background.. Whether radiation should be added to neoadjuvant treatment remains controversial, and liquid biopsy has not been reported to predict radioresistance in pancreatic cancer (PC).. We aimed to identify microRNAs (miRNAs) governing radioresistance in PC by utilizing peripheral plasma exosome samples and to verify their usefulness as biomarkers. Purification:Article Title: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Article Snippet: Makoto Chuma, 7 Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, 4 Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, 1 Kazuhisa Takeda, 1 Chikara Kunisaki, Katsuaki Ogushi, 1 Satoshi Moriya, 1 Koji Hara, 1 Akito Nozaki, 1 Masaaki Kondo, 9 Hiroyuki Fukuda, 1 Kazushi Numata, Katsuaki Tanaka, 1 Shin Maeda, and Naoya Sakamoto Control:Article Title: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Article Snippet: Makoto Chuma, 7 Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, 4 Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, 1 Kazuhisa Takeda, 1 Chikara Kunisaki, Katsuaki Ogushi, 1 Satoshi Moriya, 1 Koji Hara, 1 Akito Nozaki, 1 Masaaki Kondo, 9 Hiroyuki Fukuda, 1 Kazushi Numata, Katsuaki Tanaka, 1 Shin Maeda, and Naoya Sakamoto Expressing:Article Title: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Article Snippet: Makoto Chuma, 7 Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, 4 Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, 1 Kazuhisa Takeda, 1 Chikara Kunisaki, Katsuaki Ogushi, 1 Satoshi Moriya, 1 Koji Hara, 1 Akito Nozaki, 1 Masaaki Kondo, 9 Hiroyuki Fukuda, 1 Kazushi Numata, Katsuaki Tanaka, 1 Shin Maeda, and Naoya Sakamoto Hybridization:Article Title: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Article Snippet: Makoto Chuma, 7 Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, 4 Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, 1 Kazuhisa Takeda, 1 Chikara Kunisaki, Katsuaki Ogushi, 1 Satoshi Moriya, 1 Koji Hara, 1 Akito Nozaki, 1 Masaaki Kondo, 9 Hiroyuki Fukuda, 1 Kazushi Numata, Katsuaki Tanaka, 1 Shin Maeda, and Naoya Sakamoto Quantitative Proteomics:Article Title: Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Article Snippet: Makoto Chuma, 7 Hidenori Toyoda, Juntaro Matsuzaki, Yoshimasa Saito, 4 Takashi Kumada, Toshifumi Tada, Yuji Kaneoka, Atsuyuki Maeda, Hideki Yokoo, Koji Ogawa, Toshiya Kamiyama, Akinobu Taketomi, Yoshihiro Matsuno, Keiichi Yazawa, 1 Kazuhisa Takeda, 1 Chikara Kunisaki, Katsuaki Ogushi, 1 Satoshi Moriya, 1 Koji Hara, 1 Akito Nozaki, 1 Masaaki Kondo, 9 Hiroyuki Fukuda, 1 Kazushi Numata, Katsuaki Tanaka, 1 Shin Maeda, and Naoya Sakamoto |
